PMID: 2116386Jul 1, 1990Paper

The influence of extent and local management on the outcome of radiotherapy for brain metastases

International Journal of Radiation Oncology, Biology, Physics
P J HoskinH T Ford

Abstract

The results of cranial irradiation for brain metastases in 164 consecutive patients have been reviewed to evaluate a policy of localized high dose irradiation for solitary metastases. Fifty of the 164 patients receiving whole brain irradiation (35 Gy in 15 daily fractions) were selected for boosts delivering 15 Gy in 8 daily fractions to the site of solitary deposits. No difference in overall survival or the incidence of death from progressive brain metastases was seen between the patients receiving a boost and those who did not. Overall median survival was 112 days with 62% of patients dying from metastatic disease outside the brain. Factors associated with increased survival were early response to radiotherapy and, in breast cancer patients, a disease-free interval of 2 years. Palliation of presenting symptoms was achieved in 86% of patients at 3 weeks from starting radiotherapy. It is concluded that whereas whole brain irradiation results in useful symptom control, there is no advantage for high dose treatment in the majority of patients with solitary metastases even in the absence of metastatic disease elsewhere.

References

Nov 1, 1979·Cancer·A DiStefanoG R Blumenschein
Sep 15, 1986·Cancer·D P Sarma, T G Weilbaecher

❮ Previous
Next ❯

Citations

Feb 1, 1993·Journal of Neuro-oncology·W BoogerdG Baris
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·K HayakawaH Niibe
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M NozakiH Niibe
Nov 25, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Masakazu OguraMasahiro Hiraoka
Mar 26, 2005·World Journal of Urology·Alexander MuacevicBerndt Wowra
Feb 8, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alina SturdzaAndrea Bezjak
Jul 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·W Boogerd
Sep 1, 1996·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·F BachS A Engelholm
Jan 15, 1995·International Journal of Radiation Oncology, Biology, Physics·G F RyanJ G Smith
Sep 30, 1995·International Journal of Radiation Oncology, Biology, Physics·C NiederK Schnabel
Feb 1, 1996·International Journal of Radiation Oncology, Biology, Physics·W W WongE G Shaw
May 15, 1995·International Journal of Radiation Oncology, Biology, Physics·L B Marks, E C Halperin
Aug 27, 2013·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·D Antoni, G Noël
Oct 2, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A BezjakN Laperriere
Nov 19, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C NiederK Schnabel
Oct 31, 2003·Cancer Treatment Reviews·Roy A Patchell
Mar 1, 1997·International Journal of Radiation Oncology, Biology, Physics·L GasparR Byhardt
Mar 6, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M SenM Kinay
Jan 1, 1996·Cancer Investigation·R A Patchell
Nov 4, 2011·Clinical Neurology and Neurosurgery·Melike Mut
Jul 16, 2011·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A LévyA Assouline
May 31, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Avi AssoulineClaude Krzisch
Nov 27, 2010·Neurosurgery Clinics of North America·Robert B Den, David W Andrews
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·L R CoiaT J Priestman
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·L R Coia
Dec 17, 2009·Critical Reviews in Oncology/hematology·Gianluca TomaselloMartine J Piccart-Gebhart
Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·E M NoordijkA R Wattendorff
Jul 31, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·E SadikovN Laperriere
Oct 24, 2006·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·G Noel
Jul 1, 2004·Surgical Neurology·Jason SheehanL Dade Lunsford
Aug 1, 1991·Journal of Pain and Symptom Management·M Ashby
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E J Maher
Mar 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G StevensA Coates
Jan 5, 2002·Hematology/oncology Clinics of North America·S M Arnold, R A Patchell
May 31, 2011·International Journal of Radiation Oncology, Biology, Physics·Christina H SonHelen A Shih
Jan 1, 1996·Acta Oncologica·R G Parker
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xuling Lin, Lisa M DeAngelis
Dec 8, 2004·Critical Reviews in Oncology/hematology·Alicia TosoniAlba A Brandes
Dec 17, 2008·Journal of Neurosurgery·Heon YooSeung Hoon Lee
Apr 12, 2003·Technology in Cancer Research & Treatment·Paul W Sperduto
Oct 9, 2018·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Yoon Hwan ByunSeung Hoon Lee
May 10, 2005·BJU International·Michael StaehlerMichael Siebels
Jan 15, 2000·Surgical and Radiologic Anatomy : SRA·J J HermansR L Diercks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.